Purplish Terminal Ileum: Adult IgA Vasculitis Mimicking Crohn's Disease Authors: Julian Diaz-Moreno, Rimsha Naeem, James Kruer, Sankalp Dwivedi Published: 2026 ABSTRACT Immunoglobulin A (IgA) vasculitis is a systemic small-vessel vasculitis with frequent gastrointestinal involvement; however, isolated terminal ileitis mimicking Crohn's disease is rare in adults. We report a case of a previously healthy adult patient who presented with acute abdominal pain and bloody diarrhea, with imaging and endoscopic findings suggestive of Crohn's disease. Colonoscopy revealed isolated terminal ileitis with a distinctive purplish cyanotic appearance. The development of palpable purpura and biopsies demonstrating IgA deposition in the skin and ileal tissue confirmed the diagnosis of IgA vasculitis. Recognition of characteristic endoscopic vascular features is critical to avoid misdiagnosis and inappropriate biological therapy. INTRODUCTION Immunoglobulin A (IgA) vasculitis (IgAV), formerly known as Henoch-Schönlein purpura, is an IgA-mediated systemic vasculitis characterized by palpable purpura, arthralgia or arthritis, gastrointestinal and renal involvement. More than two-thirds of adult patients with IgAV present with gastrointestinal manifestations, which may precede other systemic features.1 In adults, the annual incidence of IgA vasculitis is 0.1–1.8 per 100,000 and the disease occurs more commonly in males (1.5:1).2 When the gastrointestinal tract is involved, the duodenum and terminal ileum are most frequently affected.3 Terminal ileitis in IgAV can closely mimic Crohn's disease (CD), creating a diagnostic challenge, particularly when gastrointestinal symptoms precede cutaneous or renal findings.4 We describe a case of adult-onset IgAV presenting with isolated terminal ileitis initially suspected to represent CD. CASE REPORT A 26-year-old transgender man presented to the emergency department with acute-onset abdominal pain (onset approximately 4 hours before presentation) and multiple episodes of bloody diarrhea. The patient had a past medical history of attention-deficit/hyperactivity disorder, anxiety, and depression. In the days preceding hospitalization, the patient reported evolving palpable purpura of the lower extremities that had first appeared approximately 2 weeks before admission. There was no history of inflammatory bowel disease, recent infection, or relevant medication use. There was no family history of autoimmune disease, IgA vasculitis, or inflammatory bowel disease. On physical examination, vital signs were stable. Abdominal examination revealed diffuse tenderness without peritoneal signs. The cutaneous findings were subtle and nonconfluent. Laboratory evaluation demonstrated leukocytosis (24,000 cells/μL), elevated erythrocyte sedimentation rate, markedly increased C-reactive protein (40.3 mg/dL), and thrombocytosis (679,000/μL). Computed tomography of the abdomen and pelvis showed inflammatory fat stranding and marked wall thickening of the terminal ileum, consistent with terminal ileitis (Figure 1). Contrast-enhanced computed tomography abdomen and pelvis demonstrating terminal ileitis (yellow arrows; annotated label: Terminal ileitis). Gastrointestinal infectious workup was performed on admission. Stool cultures were negative for Campylobacter, Salmonella, Shiga toxin-producing organisms, Shigella, Vibrio, and Yersinia. Given the computed tomography finding of terminal ileitis and the patient's acute presentation with bright red blood per rectum without upper gastrointestinal symptoms, an esophagogastroduodenoscopy was not performed, and colonoscopy was pursued as the primary diagnostic procedure. Colonoscopy revealed a normal colon and isolated terminal ileitis. The ileal mucosa appeared purplish and cyanotic with areas of ulceration (Figures 2 and 3). Random colonic biopsies were obtained despite the grossly normal-appearing colonic mucosa; these were histopathologically negative. Fecal calprotectin was not obtained at presentation, as the clinical picture was characterized by acute-onset abdominal pain with bright red blood per rectum rather than chronic diarrhea, and colonoscopy was prioritized as the primary diagnostic modality. Colonoscopy image demonstrating purplish-cyanotic terminal ileal mucosa with mucosal edema and overlying exudate. Colonoscopy image showing deep ulceration with overlying exudate against a background of cyanotic, congested terminal ileal mucosa. Skin biopsies were performed given progression of the purpuric rash and demonstrated leukocytoclastic vasculitis with IgA deposition. Terminal ileal biopsies revealed severe acute ileitis characterized by ulceration and mucosal necrosis. Histopathologic examination demonstrated areas of leukocytoclastic vasculitis (Figure 4). No granulomas were identified. These findings, together with the cutaneous biopsy results, established the diagnosis of IgAV with gastrointestinal involvement. Terminal ileal biopsy (hematoxylin and eosin stain, original magnification ×20) demonstrating severe acute ileitis. Black arrows identify blood vessels with vasculitis. No granulomas were identified. The patient was started on prednisone 40 mg daily with rheumatology follow-up. Corticosteroids were tapered over 8 weeks. Renal function remained normal, and no hematuria or proteinuria was observed. Within 4 weeks, abdominal pain and bloody diarrhea resolved, and the purpuric rash improved. At the 3-month follow-up, magnetic resonance enterography demonstrated resolution of terminal ileal inflammation, consistent with radiologic remission. DISCUSSION Adult-onset IgAV is uncommon and may present with more severe or atypical manifestations than pediatric disease.5 Gastrointestinal involvement is well recognized in IgAV, with terminal ileal involvement reported in up to half of affected patients. However, isolated terminal ileitis as the predominant and initial manifestation is rare. The clinical presentation of IgAV can mimic CD particularly when extraintestinal features are subtle or delayed. Figures 5 and 6 compare the gastrointestinal involvement and underlying mechanisms of CD and IgAV. Pathological mechanisms in gastrointestinal involvement: key differences between Crohn's disease and IgA vasculitis pathogenesis and gastrointestinal complications. IgA, immunoglobulin A. Crohn's disease vs IgA vasculitis: gastrointestinal tract involvement compared across disease pattern, sites affected, granulomas, fistulas, disease course, age of onset, and key diagnostic features. IgA, immunoglobulin A. The initial presentation in this case (acute abdominal pain, bloody diarrhea, elevated inflammatory markers, and cross-sectional imaging demonstrating terminal ileitis) strongly suggested CD. Terminal ileitis has a broad differential diagnosis that includes inflammatory bowel disease, infection, medication-related injury, Behçet's disease, and vasculitides.6 Beyond diagnostic mimicry, the literature supports a nonrandom association between IgAV and CD. Rasmussen et al,7 reported on 43 cases of IgAV arising in the setting of inflammatory bowel disease (IBD), found that CD accounted for 58% of cases and that IBD preceded IgAV by a median of 9.2 years. Systematic review data from Sy et al8 further confirm that vasculitis, including IgAV, co-occurs with IBD at rates exceeding chance expectation. The biological plausibility of this association may be explained by dysregulation of mucosal IgA immunity, potentially representing an extraintestinal manifestation of CD driven by the extension of aberrant mucosal immune responses beyond the gut.9 The gut-associated lymphoid tissue, particularly the Peyer's patches concentrated in the distal ileum, represents the primary inductive site of mucosal IgA synthesis.10 In a mechanism analogous to that proposed in IgA nephropathy, chronic mucosal inflammation in CD overstimulates gut-associated lymphoid tissue B cells, shifting immunoglobulin production from IgA2 toward IgA1 and promoting aberrant O-glycosylation of the IgA1 hinge region.11 The resulting galactose-deficient IgA1 (Gd-IgA1) is the same aberrantly glycosylated molecule responsible for circulating immune complex formation in both IgAV and IgA Nephropathy (IgAN).12 The terminal ileum therefore serves as a primary anatomical origin of vasculogenic IgA1, suggesting that the convergence of CD and IgAV at this site reflects a shared immunological substrate rather than coincidental coexistence.13 This case also raises the important question of whether IgAV and CD can coexist as parallel immune processes. Endoscopic findings provided an important diagnostic clue. IgAV should be considered in patients presenting with terminal ileitis when endoscopy reveals mucosal edema, erythema, erosions, and ulcerations, as described in the literature.3 In our patient, a distinctive purplish-cyanotic mucosal appearance was observed—an atypical feature for CD—which raised suspicion for an alternative underlying vascular etiology. These findings contrast with the typical endoscopic appearance of CD, characterized by aphthous ulcers, longitudinal ulcerations, cobble stoning, and skip lesions without mucosal cyanosis.14 Awareness of these vascular-appearing mucosal changes is critical when evaluating terminal ileitis of unclear etiology, particularly in the setting of acute presentation and concurrent or evolving cutaneous findings. Definitive diagnosis relies on histopathologic confirmation of leukocytoclastic vasculitis with IgA deposition on immunofluorescence.15 While skin biopsy is often sufficient, gastrointestinal biopsies can confirm intestinal involvement and are especially valuable when the presentation mimics inflammatory bowel disease. In this case, concordant IgA deposition in both skin and terminal ileal biopsies established the diagnosis and prevented initiation of biologic therapy for presumed CD. The rapid clinical response to systemic corticosteroids further supported the diagnosis. Subsequent normalization of fecal calprotectin and resolution of inflammation on magnetic resonance enterography were consistent with complete remission, a course more characteristic of IgAV than the protracted or relapsing trajectory typically seen in CD.4,16 Renal involvement, a major determinant of long-term prognosis in IgAV, was absent in this patient at presentation and during follow-up. Although nephritis occurs in a substantial proportion of adults, its absence at initial evaluation does not exclude the diagnosis, as renal manifestations may develop weeks to months after disease onset. This underscores the importance of continued and longitudinal renal function surveillance.17 In conclusion, IgAV should be considered in adults presenting with acute terminal ileitis, particularly when endoscopic findings reveal purplish or cyanotic mucosal changes and cutaneous manifestations are present or evolving. Early recognition and histologic confirmation, including gastrointestinal biopsy when the presentation mimics CD, are essential to establish the correct diagnosis and prevent unnecessary biologic therapy. DISCLOSURES Author contributions: J. Diaz-Moreno, R. Naeem, J. Kruer and S. Dwivedi all participated in the conception, drafting, writing and editing, reviewing, final approval and agree to be accountable for all aspects of the work. J. Diaz-Moreno is the article guarantor. Financial disclosure: None to report. Informed consent was obtained for this case report.